Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05417321 · ClinicalTrials.gov registry record · Phase 1

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor and NSCLC, sponsored by Shanghai Huaota Biopharmaceutical Co..

Recruiting
Registry status
Phase 1
Development phase
80
Enrollment target
4
Study locations

NCT05417321 is a Phase 1 study of Advanced Solid Tumor and NSCLC that is actively recruiting participants, run by Shanghai Huaota Biopharmaceutical Co.. The registered enrollment target is 80 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (59% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05417321, a Phase 1 study of Advanced Solid Tumor and NSCLC, is actively recruiting participants, sponsored by Shanghai Huaota Biopharmaceutical Co..

RECRUITING
Registry status
Phase 1
Development phase
80 participants
Enrollment target
4
Study locations

Study Summary

It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors

Conditions Studied

Advanced Solid Tumor NSCLC

Interventions

  • DRUG HB0036

Study Locations (4)

Indiana

  • Horizon Oncology - Lafayette

Texas

  • Next Oncology - San Antonio

Washington

  • Summit Cancer Centers - Spokane

Shandong

  • Shandong Hospital - Jinan

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-08-25
Est. Completion 2025-08-01
Phase Phase 1

Sponsor

Shanghai Huaota Biopharmaceutical Co.

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05417321

The ClinicalTrials.gov registry entry for NCT05417321 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (59% lower). The listed sponsor is Shanghai Huaota Biopharmaceutical Co., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which HB0036 is the first listed.

NCT05417321 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Indiana, Texas, Washington.

Frequently Asked Questions

What is clinical trial NCT05417321 about?

NCT05417321 is a clinical study titled "A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors". It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors

What is the current status of trial NCT05417321?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2022-08-25. Estimated completion is 2025-08-01.

What conditions does trial NCT05417321 study?

This clinical trial studies the following conditions: Advanced Solid Tumor, NSCLC.

What interventions are being tested in trial NCT05417321?

The interventions under investigation include: HB0036 (DRUG).

Who is sponsoring clinical trial NCT05417321?

This trial is sponsored by Shanghai Huaota Biopharmaceutical Co., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05417321 being conducted?

This trial has 4 study locations across Indiana, Texas, Washington, Shandong. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

NSCLC

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.